Stocktoria
Cresco Labs Inc. CRLBF
Cresco Labs Inc. (CRLBF) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $655.8M at a -20.6% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Manufacturing · percentile among 1829 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.133 |
| Retained earnings / assets | -1.253 |
| EBIT / assets | -0.023 |
| Equity / liabilities | 0.36 |
Detailed pages
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CRLBF | Cresco Labs Inc. | 3/9 | -2.99 | — | -9.5% |
| AAWH | Ascend Wellness Holdings, Inc. | 4/9 | -1.32 | — | -10.9% |
| TLRY | Tilray Brands, Inc. | 4/9 | -11.01 | — | +4.1% |
| USNA | USANA HEALTH SCIENCES INC | 6/9 | 7.37 | 32.6 | +8.3% |
| CGC | Canopy Growth Corp | 4/9 | — | — | +10.5% |
| JUSHF | Jushi Holdings Inc. | 3/9 | -4.96 | — | +2.1% |
| CRON | Cronos Group Inc. | 6/9 | — | — | +19.5% |
FAQ
Is CRLBF financially healthy?
Cresco Labs Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does CRLBF pay a dividend?
No, Cresco Labs Inc. does not currently pay a dividend.
How profitable is CRLBF?
In FY2025, Cresco Labs Inc. had a net margin of -20.6% and a return on equity of -39.8%.
Source: SEC EDGAR filings · CIK 0001832928 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.